Back
PTC Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Buy
64
PTCT
PTC Therapeutics
Last Price:
32.30
Seasonality Move:
20.4%
Buy
65
CATX
Perspective Therapeutics
Last Price:
1.75
Seasonality Move:
2.36%
Buy
64
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $32.25. The Score for PTCT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PTCT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.75. The Score for CATX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $32.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.75
The current trend is moderately bullish and CATX is experiencing slight buying pressure.
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.26 | Buy |
| Relative Strength Index (14 RSI): | 61.44 | Buy |
| Chaikin Money Flow: | 281278 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.4 - 31.9) | Buy |
| Bollinger Bands (100): | (25.94 - 30.42) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 61.6 | Buy |
| Chaikin Money Flow: | 980286 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.49 - 1.75) | Buy |
| Bollinger Bands (100): | (0.59 - 1.47) | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.5 | Sell |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 29.19 | Buy |
| 200-day SMA: | 28.34 | Buy |
| 8-day EMA: | 31.6 | Buy |
| 20-day EMA: | 30.22 | Buy |
| 50-day EMA: | 28.99 | Buy |
| 200-day EMA: | 30.25 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.78 | Sell |
| 20-day SMA: | 1.65 | Buy |
| 50-day SMA: | 1.4 | Buy |
| 200-day SMA: | 0.68 | Buy |
| 8-day EMA: | 1.76 | Sell |
| 20-day EMA: | 1.66 | Buy |
| 50-day EMA: | 1.42 | Buy |
| 200-day EMA: | 0.87 | Buy |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, an increase next quarter of $0.44 per share, a decrease this year of $0.61 per share, and an increase next year of $1.56 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||